Project/Area Number |
22590309
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Human pathology
|
Research Institution | Tokyo Medical and Dental University |
Principal Investigator |
AKASHI Takumi 東京医科歯科大学, 医学部附属病院, 准教授 (60242202)
|
Co-Investigator(Kenkyū-buntansha) |
FUJIWARA Naoyuki 東京医科歯科大学, 医学部附属病院, 助教 (80451912)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 肺癌 / 極性 / 浸潤突起 / 浸潤 / 極性異常 / 基底膜 / 細胞極性 / ect2 / cortactin / actinin1 |
Research Abstract |
Epithelial cells have an apical surface facing a lumen and a basal surface facing extracellular matrix. Abnormality of apical-basal polarity in neoplastic change was examined in the aspect of localization of invadopodia proteins in lung adenocarcinomas. Actinin-1 and cortactin showed matrix-contact-side localization in adenocarcinoma cells, but rarely in normal bronchiolar epithelial cells, alveolar cells, or precursor neoplastic lesions. Matrix-contact-side localization of invadopodia-related proteins could be histological markers indicative for invasion, metastasis, and poor prognosis. Rho guanine exchange factor/Ect2, one of Par6-binding proteins, was a possible regulator of polarity abnormality in lung adenocarcinomas.
|